Molecular surveillance of the on-going SARS-COV-2 epidemic in Ribeirao Preto City, Brazil.


Journal

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
ISSN: 1567-7257
Titre abrégé: Infect Genet Evol
Pays: Netherlands
ID NLM: 101084138

Informations de publication

Date de publication:
09 2021
Historique:
received: 16 12 2020
revised: 18 06 2021
accepted: 21 06 2021
pubmed: 27 6 2021
medline: 14 9 2021
entrez: 26 6 2021
Statut: ppublish

Résumé

The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of an unprecedented worldwide pandemic. Brazil demonstrates one of the highest numbers of confirmed SARS-CoV-2 cases, and São Paulo State is the epicenter of the pandemics in the country. Nevertheless, little is known about the SARS-CoV-2 circulation in other cities in the State than São Paulo city. The objective of this study was to analyze phylogenetically SARS-CoV-2 strains circulating in city of Ribeirão Preto at the beginning of the pandemic and during the actual second wave. Twenty-nine nasopharyngeal SARS-CoV-2 RNA positive samples were sequenced by nanopore technology (18 obtained at the initial period of the pandemic and 11 during the second wave) and analyzed them phylogenetically. The performed analysis demonstrated that the majority of the strains obtained in the initial period of the pandemic in Ribeirão Preto belonged mainly to the B1.1.33 lineage (61.1%), but B.1.1 (27.8%) and B.1.1.28 (11.1%) lineages were also identified. In contrast, the second wave strains were composed exclusively by the Brazilian variant of concern (VOC) P.1 (91%) and P.2 (9%) lineages. The obtained phylogenetic results were suggestive of successive SARS-CoV-2 lineage substitution in this Brazilian region by the P.1 VOC. The performed study examines the SARS-CoV-2 genotypes in Ribeirão Preto city via genomic surveillance data. The obtained findings can contribute for continuous long-term genomic surveillance of SARS-CoV-2 due to the accelerated dynamics of viral lineage substitution, predict further waves and examine lineage behavior during SARS-CoV-2 vaccination.

Identifiants

pubmed: 34174479
pii: S1567-1348(21)00273-2
doi: 10.1016/j.meegid.2021.104976
pmc: PMC8223017
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104976

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Références

Bioinformatics. 2020 Jun 1;36(11):3552-3555
pubmed: 32108862
Nature. 2021 Apr;592(7854):438-443
pubmed: 33690265
Nat Med. 2020 Apr;26(4):450-452
pubmed: 32284615
Nat Protoc. 2017 Jun;12(6):1261-1276
pubmed: 28538739
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
Bioinformatics. 2019 Mar 1;35(5):871-873
pubmed: 30124794
Science. 2020 Sep 4;369(6508):1255-1260
pubmed: 32703910
Nat Med. 2021 Jul;27(7):1230-1238
pubmed: 34035535
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Brief Bioinform. 2019 Jul 19;20(4):1160-1166
pubmed: 28968734
Nature. 2021 May;593(7858):266-269
pubmed: 33767447
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Nat Med. 2020 Oct;26(10):1609-1615
pubmed: 32747830
Bioinformatics. 2014 Nov 15;30(22):3276-8
pubmed: 25095880

Auteurs

Svetoslav Nanev Slavov (SN)

Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.

Marta Giovanetti (M)

Laboratório de Flavivírus, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil; Laboratório de Genética Celular e Molecular, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

Rafael Dos Santos Bezerra (R)

Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.

Vagner Fonseca (V)

Laboratório de Genética Celular e Molecular, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), College of Health Sciences, University of KwaZuluNatal, Durban 4001, South Africa.

Elaine Vieira Santos (EV)

Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.

Evandra Strazza Rodrigues (ES)

Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.

Talita Adelino (T)

Laboratório de Genética Celular e Molecular, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Laboratório Central de Saúde Pública, Fundação Ezequiel Dias, Belo Horizonte, Brazil.

Joilson Xavier (J)

Laboratório de Genética Celular e Molecular, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

Josiane Serrano Borges (JS)

Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.

Mariane Evaristo (M)

Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.

Mauricio Teixeira Lima (MT)

Laboratório de Genética Celular e Molecular, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

Glauco de Carvalho Pereira (G)

Laboratório Central de Saúde Pública, Fundação Ezequiel Dias, Belo Horizonte, Brazil.

Aparecida Yulie Yamamoto (AY)

Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Brazil.

Diego Villa Clé (DV)

Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Brazil.

Rodrigo Tocantins Calado (RT)

Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Brazil.

Dimas Tadeu Covas (DT)

Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Brazil.

Luiz Carlos Junior Alcantara (LCJ)

Laboratório de Flavivírus, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil; Laboratório de Genética Celular e Molecular, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

Simone Kashima (S)

Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. Electronic address: skashima@hemocentro.fmrp.usp.br.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH